Dr. Nicole Carter highlights the critical need for continued federal investment in cancer research and prevention programs, particularly in rural communities. She emphasizes that funding through the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) is vital for improving access to clinical trials and cutting-edge treatments. Such investments also…

The Trump administration is opening new avenues for Medicaid funding through state-directed payments, potentially reshaping financial strategies for healthcare providers. This move comes amid ongoing discussions about potential cuts to healthcare funding under a proposed bill. The changes could significantly impact how states allocate resources and manage Medicaid programs, influencing both state budgets and healthcare…

Recent changes to U.S. vaccine recommendations have sparked concerns among healthcare professionals about increasing vaccine hesitancy. The new guidelines, which shift from blanket recommendations to ‘shared clinical decision-making’ for certain vaccines, are seen as potentially confusing for parents and challenging for pediatricians. Critics argue that this could lead to lower vaccination rates and increased illness…

A federal appeals court has halted a Trump administration initiative requiring hospitals to pay full prices upfront for certain medications, delaying rebates. The 1st U.S. Circuit Court of Appeals upheld an injunction against the Health Resources and Services Administration’s 340B Rebate Model Pilot Program. The American Hospital Association argued the program violated the Administrative Procedure…

President Trump announced plans to meet with representatives from 14 major health insurance companies to discuss reducing insurance costs. This follows the expiration of COVID-era subsidies under the Affordable Care Act (ACA), which has led to potential premium increases for millions of Americans. Despite the lack of congressional action to extend these subsidies, Trump suggests…

The U.S. is experiencing a severe flu season, with infections surpassing last winter’s levels. The H3N2 strain, particularly the new K variant, is prevalent, raising concerns about vaccine effectiveness. Despite the surge, the Trump administration has stopped recommending flu vaccines for children, shifting the decision to parents and doctors. This policy change coincides with a…